Nanobiotix S.A.
NBTX
$51.50
-$3.57-6.48%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -27.56M | -41.40M | -55.97M | -64.69M | -73.73M |
| Total Depreciation and Amortization | 1.68M | 1.72M | 1.77M | 1.74M | 1.75M |
| Total Amortization of Deferred Charges | 4.60K | 5.50K | 6.50K | 5.40K | 4.30K |
| Total Other Non-Cash Items | -7.76M | 4.02M | 16.28M | 26.12M | 35.37M |
| Change in Net Operating Assets | -4.09M | -55.90K | 4.02M | 9.67M | 15.44M |
| Cash from Operations | -37.72M | -35.71M | -33.89M | -27.15M | -21.16M |
| Capital Expenditure | -616.60K | -581.10K | -550.50K | -728.60K | -915.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -45.80K | -81.70K | -119.20K | -118.30K | -118.00K |
| Cash from Investing | -662.40K | -662.80K | -669.70K | -846.90K | -1.03M |
| Total Debt Issued | 42.93M | 21.47M | -- | -- | -- |
| Total Debt Repaid | -4.74M | -4.67M | -4.60M | -4.38M | -4.16M |
| Issuance of Common Stock | 1.54M | 767.50K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.31M | -1.51M | -707.00K | -843.50K | -980.00K |
| Cash from Financing | 43.86M | 19.11M | -5.78M | -5.60M | -5.55M |
| Foreign Exchange rate Adjustments | -431.30K | -469.90K | -508.00K | -192.70K | 101.60K |
| Miscellaneous Cash Flow Adjustments | 100.00 | -500.00 | -1.10K | -500.00 | -- |
| Net Change in Cash | 5.04M | -17.73M | -40.85M | -33.79M | -27.64M |